Martin Dossenbach - Eli Lilly & Co GesmbH

基本信息

浏览量：40

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 67 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Novel Efficacy Index for Long-Term Therapy Outcomes Expressed by Maintenance of EASI 75 and IGA 0,1 Response in Atopic Dermatitis

Jonathan Silverberg,Alan Irvine,Peter Foley, James Del Rosso, Alexander Schacht,Martin Dossenbach,Marta Casillas,Erin Johansson,Gaia Gallo,Linda Stein Gold

BRITISH JOURNAL OF DERMATOLOGY (2024)

引用0浏览0引用

50351 Lebrikizumab Maintains Clinically Meaningful Outcomes with Treatment Administered Every 4 Weeks in Adult and Adolescent Patients with Moderate-to-severe Atopic Dermatitis

Linda Stein Gold,Marie Louise Schuttelaar,Vimal H. Prajapati,Bernhard Homey,Lindsay Strowd,Martin Dossenbach, Chunyuan Liu, Jinglin Zhong,Evangeline Pierce,Helena Agell,Juan Francisco Silvestre

Journal of the American Academy of Dermatologyno. 3 (2024): AB58

引用0浏览0引用

51075 HADS Anxiety and Depression Scores Improved in Japanese Patients with Moderate-to-severe Atopic Dermatitis Following Lebrikizumab Treatment: 16-Week Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial (Adhere-J)

Takeshi Nakahara, Yuichiro Tsunemi,Hitoe Torisu-Itakura,Yoji Morisaki,Evangeline Pierce,Martin Dossenbach,Hidehisa Saeki

Journal of the American Academy of Dermatologyno. 3 (2024): AB49

引用0浏览0引用

Efficacy Comparison of Targeted Systemic Monotherapies Including Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: a Network Meta-Analysis

Jonathan Silverberg,Thomas Bieber,Amy Paller,Lisa A. Beck,Masahiro Kamata,Luis Puig,Marni Wiseman,Khaled Ezzedine,Peter Foley,Erin Johansson,Martin Dossenbach, Bulent Akmaz,Marta Casillas, Andrei Karlsson,Raj Chovatiya

BRITISH JOURNAL OF DERMATOLOGY (2024): 15-16

引用0浏览0引用

Lebrikizumab is an Effective Treatment for Moderate-to-severe Atopic Dermatitis in Patients ≥60 Years of Age

April Armstrong,Matthew Zirwas,Maddalena Napolitano,Tiago Torres,Delphine Staumont-Salle,Amber Reck Atwater,Martin Dossenbach,Helena Agell,Sherry Chen, Meihua Qiao,Evangeline Pierce,Maria Lucia Buziqui Piruzeli,Arash Mostaghimi

BRITISH JOURNAL OF DERMATOLOGY (2024)

引用0浏览0引用

Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12

Alice B. Gottlieb,Daniel Saure,Stefan Wilhelm,Martin Dossenbach,Christopher Schuster,Saxon D. Smith,Yuval Ramot,Diamant Thaci

JOURNAL OF DERMATOLOGICAL TREATMENT（2022）

引用7浏览0WOS引用

Network Meta‐analysis of Biologic Treatments for Psoriasis Using Absolute Psoriasis Area and Severity Index Values ≤1, 2, 3 or 5 Derived from a Statistical Conversion Method

U. Mrowietz,R. B. Warren,C. L. Leonardi,D. Saure, H. Petto,S. Hartz,M. Dossenbach,K. Reich

JEADV Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy...（2021）

引用14浏览0WOS引用

比较生物制剂依奇珠单抗与其他两种治疗银屑病的药物富马酸酯和甲氨蝶呤的试验

K. Reich, M. Augustin,D. Thaçi,A. Pinter,A. Leutz,C. Henneges, E. Schneider,A. Schacht,M. Dossenbach,U. Mrowietz

British journal of dermatology/British journal of dermatology, Supplementno. 4 (2020)

引用0浏览0引用

A trial to compare the biologic drug ixekizumab with two other treatments for psoraisis, fumaric acid esters and methotrexate

K. Reich, M. Augustin,D. Thaçi,A. Pinter,A. Leutz,C. Henneges, E. Schneider,A. Schacht,M. Dossenbach,U. Mrowietz

British Journal of Dermatology（2020）

引用0浏览0引用

A 24-Week Multicentre, Randomized, Open-Label, Parallel-Group Study Comparing The Efficacy And Safety Of Ixekizumab Vs. Fumaric Acid Esters And Methotrexate In Patients With Moderate-To-Severe Plaque Psoriasis Naive To Systemic Treatment

K Reich,M Augustin,D Thaçi,A Pinter,A Leutz,C Henneges,E Schneider,A Schacht,M Dossenbach,U Mrowietz

BRITISH JOURNAL OF DERMATOLOGY（2020）

引用26浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn